Sodium Citrate in SERS Substrate Fabrication: Protocols & Tr
2026-06-17
Sodium citrate is pivotal in the scalable, reproducible assembly of gold nanocluster arrays for SERS detection. This article translates recent advances into actionable workflows, with protocol parameters and troubleshooting tailored to maximize sensitivity and uniformity in nanofabrication.
Tamsulosin in Translational Urology: Mechanisms, Meta-Analys
2026-06-17
This thought-leadership article delivers a deep mechanistic and strategic analysis of Tamsulosin, integrating cutting-edge evidence, translational protocol guidance, and competitive insights for researchers in urological disease and smooth muscle physiology. Drawing from recent meta-analyses and advanced workflow resources, it offers actionable recommendations while highlighting new frontiers for GPCR pathway interrogation and clinical translation.
FLT3-ITD Mislocalization Drives ADC Resistance in AML Cells
2026-06-16
This study reveals that antibody-drug conjugate (ADC) efficacy in acute myeloid leukemia (AML) is limited by the impaired lysosomal trafficking of the FLT3-ITD receptor in MV4-11 cells. The findings highlight how subcellular receptor localization, rather than target presence alone, can critically dictate ADC potency and resistance mechanisms.
Carbapenemase Genes in Enterobacter cloacae: Transmission an
2026-06-16
This study characterizes the distribution, genetic context, and transmission dynamics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae isolates from hospitals in Guangdong, China. Its findings reveal high prevalence and mobility of blaNDM-1 and related resistance determinants, with implications for antibiotic stewardship and molecular epidemiology.
Novobiocin Sodium (B1992): Reliable DNA Replication Inhibito
2026-06-15
This article delivers an evidence-based, scenario-driven exploration of Novobiocin Sodium (SKU B1992) for cell viability, proliferation, and cytotoxicity assays. Addressing real laboratory challenges, it demonstrates how Novobiocin Sodium optimizes DNA gyrase inhibition, improves reproducibility in DNA damage studies, and offers practical protocol insights for biomedical researchers. Explore validated workflows and decision criteria for selecting APExBIO's Novobiocin Sodium in your laboratory.
Plant Exosome-Like Nanovesicles Alleviate Sertoli Cell Injur
2026-06-15
The referenced study demonstrates for the first time that plant-derived exosome-like nanovesicles from Cistanche deserticola (CDELNs) can target Sertoli cells and mitigate cyclophosphamide-induced testicular injury by overcoming cell cycle arrest. These findings introduce a novel cross-kingdom therapeutic approach to male reproductive toxicity, with potential for translational strategies targeting cell cycle regulators.
Dacomitinib (PF-00299804): Applied Strategies in Cancer Rese
2026-06-14
Dacomitinib (PF-00299804) stands out as a powerful tool for probing the molecular interplay between ErbB-family signaling, cell cycle regulation, and apoptosis in cancer models. Here, we detail optimized experimental workflows, integration with mitochondrial ferroptosis studies, and troubleshooting strategies to maximize reproducibility and insight.
CX-5461: Transforming Cancer Research Through Pol I Inhibiti
2026-06-13
Explore how the RNA polymerase I inhibitor CX-5461 is catalyzing a paradigm shift in cancer research and translational oncology. This article delivers mechanistic insight, highlights recent advances in cervical cancer models, and offers strategic guidance for researchers leveraging APExBIO’s CX-5461 for next-generation solid tumor studies.
TBK1 Inhibition Reduces Painful Diabetic Neuropathy via Micr
2026-06-12
Liao et al. uncover a causal role for TANK-binding kinase 1 (TBK1) in painful diabetic neuropathy (PDN), demonstrating that TBK1 activation in microglia drives pyroptosis and hyperalgesia. Their findings suggest that targeting TBK1—specifically through amlexanox administration—could provide a new therapeutic strategy for PDN, with significant implications for diabetes research and neuroinflammation modeling.
SNAI1–PIK3R2/p-EphA2 Axis Drives EMT and Stemness in Thymic
2026-06-12
This study identifies SNAI1 as a central driver of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs) via the PIK3R2/p-EphA2 axis. Through integrated multi-omics and functional analyses, the research uncovers mechanistic underpinnings of TET aggressiveness and highlights potential molecular targets for therapy.
Pifithrin-α (PFTα): Reliable p53 Inhibition for Apoptosis As
2026-06-11
This article addresses common laboratory challenges in apoptosis and cytotoxicity research, focusing on the validated use of Pifithrin-α (PFTα), SKU A4206. Scenario-driven Q&A blocks provide evidence-backed guidance on workflow optimization, protocol parameters, and vendor selection, highlighting how PFTα enhances experimental reproducibility and interpretability for p53-dependent pathway studies.
Flubendazole: Precision Autophagy Modulation in Cancer Resea
2026-06-11
Flubendazole stands out as a DMSO-soluble autophagy activator, offering unmatched reliability for dissecting autophagy signaling in cancer and neurodegenerative models. This article delivers actionable workflows, troubleshooting strategies, and translational insights to empower rigorous, reproducible research using APExBIO’s high-purity Flubendazole.
SD 169 (indole-5-carboxamide): Reliable p38 MAPK Inhibition
2026-06-10
This article explores real-world laboratory challenges in cell viability, apoptosis, and neuroregeneration studies, demonstrating how SD 169 (indole-5-carboxamide) (SKU C5850) from APExBIO provides consistent, data-backed solutions. Evidence from recent structural and functional studies supports its dual-action mechanism, underpinning reproducibility and precision in demanding workflows.
Berberine Hydrochloride: Optimizing Gut–Bone Axis Assays
2026-06-10
Berberine hydrochloride enables high-fidelity modeling of the gut–bone axis, uniquely leveraging tuft cell expansion and metabolic regulation. APExBIO’s high-purity reagent supports reproducible workflows in osteoimmunology, metabolic disease, and gut barrier studies, with robust troubleshooting strategies for translational research.
Caspase-4 Colorimetric Assay Kit: Precision in Pyroptosis As
2026-06-09
The Caspase-4 Colorimetric Assay Kit delivers rapid, quantitative measurement of LEVD-dependent caspase-4 activity, streamlining workflows in pyroptosis and inflammasome activation research. Its robust protocol, validated controls, and troubleshooting guidance make it a trusted choice for high-sensitivity detection of inflammatory response biomarkers.
462 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page